Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NRIX
#1905
Nurix Therapeutics, Inc. Common stock
15.970
0
+2.70%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+2.70%
Monthly Change
-18.42%
6 month change
+42.46%
Year Change
+42.46%
Previous Close
15.550
0
Open
15.970
0
Bid
Ask
Low
15.970
0
High
15.970
0
Volume
162
Markets
US Stock Market
Healthcare
NRIX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
70.84 M
75.89 M
76.24 M
76.45 M
76.88 M
102.84 M
—
Valuation ratios
Enterprise value
1.66 B
1.52 B
1.1 B
843.84 M
621.97 M
1.49 B
4.06 B
Price to earnings ratio
-8.54
-7.46
-5.54
-4.67
-3.08
-5.54
-18.83
Price to sales ratio
26.23
26.44
19.67
10.87
8.78
17.45
56.77
Price to cash flow ratio
16.7
8.36
5.78
4.35
3.15
5.87
19.16
Price to book ratio
1.39
2.74
0.62
0.5
0.39
2.72
4.24
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.1
0.09
0.09
0.07
0.17
0.11
0.44
Return on equity %
0.13
0.11
0.12
0.1
0.23
0.15
0.59
Return on invested capital %
172.78
215.2
223.7
157.94
274.54
248.16
904.34
Gross margin %
100
100
100
100
100
100
400
Operating margin %
433.83
486.73
340.67
109.68
1 157.65
612.03
2 220.03
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
388.91
440.75
305.38
98.66
1 094.77
576.13
2 074.93
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
5.28
6.46
6.26
6.82
5.35
7.02
25.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.02
0.02
0.03
0.07
0.01
0.02
0.14
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.58
0.73
0.73
0.75
0.68
0.78
2.95
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
6.16
9.08
6.58
5.79
5.1
6.84
24.31
Net current asset value per share
6.27
9.23
6.75
6.14
5.24
7
25.13
Tangible book value per share
5.18
7.85
5.76
5.34
4.42
6.22
21.73
Working capital per share
5.08
7.8
5.67
5.24
4.26
6
21.17
Book value per share
5.18
7.85
5.76
5.34
4.42
6.22
21.73
News
Nurix Therapeutics Stock Sees RS Rating Jump To 82
Nurix Therapeutics CFO Hans van Houte sells $61k in shares
Nurix Therapeutics chief legal officer Ring sells $73k in stock
Nurix Therapeutics CSO Gwenn Hansen sells $81k in shares
Stifel raises Nurix stock price target to $35 on bexobrutideg potential
Piper Sandler raises Nurix stock price target to $35 on pivotal trial plans
H.C. Wainwright raises Nurix stock price target to $32 on financial results
Nurix stock price target raised to $30 from $28 at RBC Capital
Nurix Therapeutics, Inc. (NRIX) Reports Q4 Loss, Misses Revenue Estimates
Nurix earnings beat by $0.10, revenue fell short of estimates
Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Nurix Therapeutics chief legal officer Ring sells $69,273 in stock